AIMS Co-Director Dr. Sunil Aggarwal Named Fellow of the American Academy of Hospice and Palliative Medicine

AIMS Co-Director Dr. Sunil Aggarwal Named Fellow of the American Academy of Hospice and Palliative Medicine11/11/2021

Fellows of the American Academy of Hospice and Palliative Medicine

One of the highest honors the Academy can bestow on an AAHPM member is recognized as a Fellow of the American Academy of Hospice and Palliative Medicine (FAAHPM).

This honor is achieved by members whose professional activity is devoted to the practice of hospice and palliative medicine. Fellow status is now open to all members of AAHPM. Fellows of the Academy are required to have been a member for 7 years and are active within the Academy. Physicians applicants are required to be board certified.

These individuals request and voluntarily submit applications for fellow status, inviting an evaluation of their practice by their peers of their personal integrity, knowledge of the field, professional accomplishment, and demonstrated scholarship.

About The Author

admin

Leave a Reply

Latest Blog Posts

Proactive Breast Health: Self-Care and Self-Exam Tips for Breast Cancer Prevention

Proactive Breast Health: Self-Care and Self-Exam Tips for Breast Cancer Prevention

by Clinical Consulting Team This post was written by our guest author, Raushanah Najeeullah, ND. Breast cancer affects approximately one in eight women, making it one of the most common cancers worldwide. While genetic factors can influence breast cancer risk, lifestyle choices and early detection play an important role in prevention. Nutrient and hormone influences, and possibly estrogen metabolism, might be contributors to breast cancer development. Select use of testing and addressing results, could influence optimal breast health and may be associated with reducing breast cancer risk. The DUTCH Test (Dried Urine Test for Comprehensive Hormones) provides potential valuable insights ...

Read More
New Urine Test Reduces Unnecessary Biopsies in Prostate Cancer Detection

New Urine Test Reduces Unnecessary Biopsies in Prostate Cancer Detection

Author: Raushanah Najeeullah, ND A new urine test, MyProstateScore 2.0 (MPS2), offers better accuracy for detecting high-grade prostate cancer compared to current methods. In a recent study involving over 1,500 men, MPS2 reduced unnecessary biopsies by up to 51% while still identifying significant cancers with high sensitivity. This test improves on the PSA test by specifically targeting 17 genes linked to high grade aggressive prostate cancer, making it a promising non-invasive tool for reducing the risks and discomfort associated with prostate cancer screening. Source: Tosoian JJ, Zhang Y, Xiao L, et al. Development and Validation of an 18-Gene Urine Test ...

Read More
Brain cancer update

Brain cancer update

July 12, 2024 Leanna Standish IV CURCUMIN AIMS Institute’s integrative oncology team is investigating the therapeutic effects of intravenous curcumin in treating the most aggressive type of brain cancer, called glioblastoma.  Curcumin is the molecule present in turmeric root that has anticancer activity.  Curcumin has been shown in cell culture experiments to cause the programmed death of glioblastoma cells.  We use IV curcumin in order to provide sufficient levels of curcumin to the brain that will slow tumor growth.  Our brain cancer patients are enrolled in AIMS Institute’s IRB-approved study called the AIMS CANCER OUTCOMES STUDY.  Last year we presented ...

Read More
Call Us Text Us
Skip to content